A cross-platform approach identifies genetic regulators of human metabolism and health

Nat Genet. 2021 Jan;53(1):54-64. doi: 10.1038/s41588-020-00751-5. Epub 2021 Jan 7.

Abstract

In cross-platform analyses of 174 metabolites, we identify 499 associations (P < 4.9 × 10-10) characterized by pleiotropy, allelic heterogeneity, large and nonlinear effects and enrichment for nonsynonymous variation. We identify a signal at GLP2R (p.Asp470Asn) shared among higher citrulline levels, body mass index, fasting glucose-dependent insulinotropic peptide and type 2 diabetes, with β-arrestin signaling as the underlying mechanism. Genetically higher serine levels are shown to reduce the likelihood (by 95%) and predict development of macular telangiectasia type 2, a rare degenerative retinal disease. Integration of genomic and small molecule data across platforms enables the discovery of regulators of human metabolism and translation into clinical insights.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus, Type 2 / genetics
  • Eye Diseases / genetics
  • Gene Frequency / genetics
  • Genetic Loci
  • Genetic Pleiotropy
  • Genome, Human
  • Glucagon-Like Peptide-2 Receptor / genetics
  • Glycine / metabolism
  • Health*
  • Humans
  • Linear Models
  • Mendelian Randomization Analysis
  • Metabolism / genetics*
  • Metabolism, Inborn Errors / genetics
  • Metabolome / genetics
  • Mutation, Missense / genetics
  • Phenotype
  • Polymorphism, Single Nucleotide / genetics
  • Retinal Telangiectasis / genetics
  • Sample Size
  • Serine / metabolism

Substances

  • GLP2R protein, human
  • Glucagon-Like Peptide-2 Receptor
  • Serine
  • Glycine

Grants and funding